92 related articles for article (PubMed ID: 15477724)
1. Interferon-alpha: regulatory effects on cell cycle and angiogenesis.
Rosewicz S; Detjen K; Scholz A; von Marschall Z
Neuroendocrinology; 2004; 80 Suppl 1():85-93. PubMed ID: 15477724
[TBL] [Abstract][Full Text] [Related]
2. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.
Murphy D; Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of interferon alfa-mediated growth inhibition in human neuroendocrine tumor cells.
Detjen KM; Welzel M; Farwig K; Brembeck FH; Kaiser A; Riecken EO; Wiedenmann B; Rosewicz S
Gastroenterology; 2000 Apr; 118(4):735-48. PubMed ID: 10734025
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.
Wu WZ; Sun HC; Shen YF; Chen J; Wang L; Tang ZY; Iliakis G; Liu KD
J Cancer Res Clin Oncol; 2005 Mar; 131(3):169-78. PubMed ID: 15662525
[TBL] [Abstract][Full Text] [Related]
6. Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.
Inamura K; Matsuzaki Y; Uematsu N; Honda A; Tanaka N; Uchida K
Biochim Biophys Acta; 2005 Sep; 1745(3):401-10. PubMed ID: 16054712
[TBL] [Abstract][Full Text] [Related]
7. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
Adam L; Black PC; Kassouf W; Eve B; McConkey D; Munsell MF; Benedict WF; Dinney CP
J Urol; 2007 May; 177(5):1900-6. PubMed ID: 17437845
[TBL] [Abstract][Full Text] [Related]
9. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
10. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
[TBL] [Abstract][Full Text] [Related]
12. Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.
Shang D; Yang P; Liu Y; Song J; Zhang F; Tian Y
Cancer Invest; 2011 Jun; 29(5):347-52. PubMed ID: 21599510
[TBL] [Abstract][Full Text] [Related]
13. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
Walters DK; Jelinek DF
Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
Takemoto Y; Yano H; Momosaki S; Ogasawara S; Nishida N; Kojiro S; Kamura T; Kojiro M
Clin Cancer Res; 2004 Nov; 10(21):7418-26. PubMed ID: 15534119
[TBL] [Abstract][Full Text] [Related]
15. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
Slaton JW; Perrotte P; Inoue K; Dinney CP; Fidler IJ
Clin Cancer Res; 1999 Oct; 5(10):2726-34. PubMed ID: 10537335
[TBL] [Abstract][Full Text] [Related]
17. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
18. Effects of interferon alpha on the expression of p21cip1/waf1 and cell cycle distribution in carcinoid tumors.
Zhou Y; Wang S; Yue BG; Gobl A; Oberg K
Cancer Invest; 2002; 20(3):348-56. PubMed ID: 12025230
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors.
Zhang J; Jia Z; Li Q; Wang L; Rashid A; Zhu Z; Evans DB; Vauthey JN; Xie K; Yao JC
Cancer; 2007 Apr; 109(8):1478-86. PubMed ID: 17340592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]